480 related articles for article (PubMed ID: 28825264)
1. [Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)].
Vicente V; Martín A; Lecumberri R; Coll-Vinent B; Suero C; González-Porras JR; Marco P; Mateo J; Roldán V; Soulard S; Crespo C; Camats M;
Emergencias; 2017 Feb; 29(1):18-26. PubMed ID: 28825264
[TBL] [Abstract][Full Text] [Related]
2. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
3. Management of Severe Bleeding in Patients Treated With Oral Anticoagulants: Proceedings Monograph From the Emergency Medicine Cardiac Research and Education Group-International Multidisciplinary Severe Bleeding Consensus Panel October 20, 2018.
Gibler WB; Racadio JM; Hirsch AL; Roat TW
Crit Pathw Cardiol; 2019 Sep; 18(3):143-166. PubMed ID: 31348075
[TBL] [Abstract][Full Text] [Related]
4. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
Tummala R; Kavtaradze A; Gupta A; Ghosh RK
Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
[TBL] [Abstract][Full Text] [Related]
5. Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient.
Miyares MA; Davis K
Am J Health Syst Pharm; 2012 Sep; 69(17):1473-84. PubMed ID: 22899742
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring options and reversal agents for oral anticoagulants].
Thorup SB; Husted SE; Vang ML
Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
[TBL] [Abstract][Full Text] [Related]
7. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
Steed MB; Swanson MT
Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772
[TBL] [Abstract][Full Text] [Related]
8. [Perioperative management of direct oral anticoagulant in emergency surgery and bleeding. Haemostasis monitoring and treatment].
Hidalgo F; Gómez-Luque A; Ferrandis R; Llau JV; de Andrés J; Gomar C; Sierra P; Castillo J; Torres LM
Rev Esp Anestesiol Reanim; 2015 Oct; 62(8):450-60. PubMed ID: 25702199
[TBL] [Abstract][Full Text] [Related]
9. [Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
Boda Z
Orv Hetil; 2016 Mar; 157(12):443-50. PubMed ID: 26971644
[TBL] [Abstract][Full Text] [Related]
10. New oral anticoagulant-induced bleeding: clinical presentation and management.
Levy JH; Levi M
Clin Lab Med; 2014 Sep; 34(3):575-86. PubMed ID: 25168943
[TBL] [Abstract][Full Text] [Related]
11. [Bleedings under NOAC (non Vitamin-K dependent oral anticoagulants). Evidence and practical management].
Koscielny J; Rutkauskaite E
Hamostaseologie; 2015; 35 Suppl 1():S43-53. PubMed ID: 26540130
[TBL] [Abstract][Full Text] [Related]
12. Developing a management plan for oral anticoagulant reversal.
Dager WE
Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S21-31. PubMed ID: 23640529
[TBL] [Abstract][Full Text] [Related]
13. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
Conway SE; Hwang AY; Ponte CD; Gums JG
Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
[TBL] [Abstract][Full Text] [Related]
14. Bleeding and antidotes in new oral anticoagulants.
Majeed A; Schulman S
Best Pract Res Clin Haematol; 2013 Jun; 26(2):191-202. PubMed ID: 23953907
[TBL] [Abstract][Full Text] [Related]
15. Management of bleeding and reversal strategies for oral anticoagulants: clinical practice considerations.
Nutescu EA; Dager WE; Kalus JS; Lewin JJ; Cipolle MD
Am J Health Syst Pharm; 2013 Nov; 70(21):1914-29. PubMed ID: 24128967
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
[TBL] [Abstract][Full Text] [Related]
17. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Anticoagulation Reversal Focus on Direct Thrombin Inhibitors and Factor Xa Inhibitors.
Mancl EE; Crawford AN; Voils SA
J Pharm Pract; 2013 Feb; 26(1):43-51. PubMed ID: 23160865
[TBL] [Abstract][Full Text] [Related]
19. Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants.
Eikelboom JW; Kozek-Langenecker S; Exadaktylos A; Batorova A; Boda Z; Christory F; Gornik I; Kėkštas G; Kher A; Komadina R; Koval O; Mitic G; Novikova T; Pazvanska E; Ratobilska S; Sütt J; Winder A; Zateyshchikov D
Br J Anaesth; 2018 Apr; 120(4):645-656. PubMed ID: 29576106
[TBL] [Abstract][Full Text] [Related]
20. Reversing anticoagulation in the hemorrhaging patient.
Treml B; Oswald E; Schenk B
Curr Opin Anaesthesiol; 2019 Apr; 32(2):206-212. PubMed ID: 30817397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
